Drug Trial Radar · NCT03478982
Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
Last checked: Nov 20, 2026Latest source record: Feb 3, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
156
Actual
Start
Mar 16, 2018
Primary completion
Dec 22, 2019
Study completion Jan 4, 2020
Sponsor
- Lead sponsor
- Engage Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Mar 27, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, double-blind, randomized, parallel group, dose-ranging study to investigate the efficacy and clinical usability of STAP-001 in adult (18 years of age and older) subjects with epilepsy with a predictable seizure pattern. These subjects have an established diagnosis of focal or generalized epilepsy with a documented history of predictable seizure episodes. This is an in-patient study. The subjects will be admitted to a Clinical Research Unit (CRU) or Epilepsy Monitoring Unit (EMU) for study participation. The duration of the stay in the in-patient unit will be 2-8 days. One seizure event per subject will be treated with study medication. The duration and timing of the seizure event and occurrence of subsequent seizures will be assessed by the Staff Caregiver(s)1 through clinical observation and confirmed with video electroencephalogram (EEG).
Conditions
- Epilepsy
Interventions
Staccato AlprazolamDrug
single dose for inhalation
PlacebosDrug
single dose for inhalation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants in Each Treatment Group Achieving Seizure Activity Cessation Within 2 Minutes and no Recurrent Seizure Within 2 HoursTime frame: 2 hours post-dosing on dosing day
Locations
67 sites in 3 countries. Site status is shown where the registry gives one.
UAB Hospital
Birmingham, Alabama
University of Arizona
Phoenix, Arizona
St. Joseph's Hospital and Medical Center - Barrow Neurological Institute
Phoenix, Arizona
Clinical Trials Inc
Little Rock, Arkansas
Rancho Research Institute Inc.
Downey, California
UCLA
Los Angeles, California
Hoag Hospital
Newport Beach, California
Stanford Neuroscience Health Center
Palo Alto, California
Havana Research Institute LLC.
Pasadena, California
University of Colorado
Aurora, Colorado
Yale University
New Haven, Connecticut
VA Connecticut Healthcare System
West Haven, Connecticut
Georgetown University Hospital
Washington D.C., District of Columbia
GW Medical Faculty Associates
Washington D.C., District of Columbia
NW FL Clinical Research Group LLC
Gulf Breeze, Florida
University of Florida Health Science Center Jacksonville
Jacksonville, Florida
Mayo Clinic Florida
Jacksonville, Florida
Clinical Translational Research Site
Miami, Florida
Advanced Pharma Cr, LLC
Miami, Florida
Nicklaus Children's Hospital
Miami, Florida
AdventHealth Orlando
Orlando, Florida
Research Institute of Orlando, LLC
Orlando, Florida
NeuroMedical Research Institute
Panama City, Florida
Center for Rare Neurological Diseases
Norcross, Georgia
Clinical Research Institute
Stockbridge, Georgia
Hawaii Pacific Neuroscience
Honolulu, Hawaii
Northwestern Memorial Hospital
Chicago, Illinois
Rush University Medical Center
Chicago, Illinois
University of Kansas Medical Center
Kansas City, Kansas
Ochsner Health System
New Orleans, Louisiana
Maine Medical Center
Scarborough, Maine
Mid-Atlantic Epilepsy And Sleep Center, LLC
Bethesda, Maryland
Harvard Medical School - Brigham and Women's Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
Bronson Methodist Hospital
Kalamazoo, Michigan
SRI International
West Bloomfield, Michigan
Washington University School of Medicine
St Louis, Missouri
Impact Clinical Trials Las Vegas
Las Vegas, Nevada
JFK Medical Center
Edison, New Jersey
Institute of Neurology & Neurosurgery at St. Barnabas
Livingston, New Jersey
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.